ADC Therapeutics SA (ADCT) Q2 2022 Earnings Call Transcript

ADC Therapeutics SA (ADCT) Q2 2022 Earnings Call Transcript

On today's call, Ameet Mallik, chief executive officer; Jennifer Herron, chief commercial officer; Joe Camardo, chief medical officer; and Jenn Creel, chief financial officer, will discuss recent business highlights and review our second quarter 2022 financial results before opening the call for questions. As a reminder, this conference call may contain forward-looking statements.